Found: 5
Select item for more details and to access through your institution.
A Phase II Study of Irinotecan for Patients with Previously Treated Small-Cell Lung Cancer.
- Published in:
- Oncology, 2018, v. 94, n. 4, p. 223, doi. 10.1159/000486622
- By:
- Publication type:
- Article
Eradication of Established Murine Skin Tumors by Cyclic Chemoimmunotherapy with Cyclophosphamide and Effector T Cells.
- Published in:
- Middle East Journal of Cancer, 2011, v. 2, n. 1, p. 9
- By:
- Publication type:
- Article
Transfer of in vitro-expanded naïve T cells after lymphodepletion enhances antitumor immunity through the induction of polyclonal antitumor effector T cells.
- Published in:
- PLoS ONE, 2017, v. 12, n. 8, p. 1, doi. 10.1371/journal.pone.0183976
- By:
- Publication type:
- Article
Clinical responses to EGFR-tyrosine kinase inhibitor retreatment in non-small cell lung cancer patients who benefited from prior effective gefitinib therapy: a retrospective analysis.
- Published in:
- BMC Cancer, 2011, v. 11, n. 1, p. 1, doi. 10.1186/1471-2407-11-1
- By:
- Publication type:
- Article
Vaccination with CD133 melanoma induces specific Th17 and Th1 cell-mediated antitumor reactivity against parental tumor.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 11, p. 1597, doi. 10.1007/s00262-011-1063-x
- By:
- Publication type:
- Article